Order Entry
United States
ContactUsLinkComponent
Human Recombinant LILRA2 (from HEK293)
Human Recombinant LILRA2 (from HEK293)
Supplier:  ACROBIOSYSTEMS
Certificates
Human Recombinant LILRA2 (from HEK293)
Supplier:  ACROBIOSYSTEMS

Specifications

  • Protein/Peptide Type:
    Recombinant
  • Source:
    HEK293 cells
  • Species:
    Human
  • Storage Conditions:
    –20 °C
  • Endotoxin Content:
    Less than 1.0 EU per μg by the LAL method.
  • Biological Activity:
    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.; Measured by its binding ability in a functional ELISA. Immobilized Human ANGPTL7, His Tag (Cat. No. AN7-H52H5) at 5 μg/mL (100 μL/well) can bind Biotinylated Human LILRA2, His,Avitag (Cat. No. LI2-H82E9) with a linear range of 0.625-5 μg/mL (QC tested).
  • Gene ID:
    Q8N149-1
  • Carrier-Free:
    Y
  • Protease-free:
    Y
  • Animal-Free:
    Y
  • Protein Synonyms:
    ILT1CD85H|ILT-1|CD85h antigen|LIR-7|CD85H|CD85h|ILT1|LIR7|LILRA2|CD85 antigen-like family member H
  • Protein/Peptide Name:
    LILRA2
  • Purity:
    >90%
  • Molecular Weight:
    50.7 kDa
  • Endotoxin Level:
    Low
  • Formulation:
    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.
  • Nuclease-free:
    Y
  • Shipping Temperature:
    Powder,RT

Specifications

Frequently Bought Together